A kind of medicine for preventing and treating diabetes and hyperlipidemia and its application in pharmacy
A technology of hyperlipidemia and drugs, applied in the field of medicine, can solve the problems of unreported pharmacological effects
Image
Examples
Embodiment 1
[0022] Tinospora chinensis was collected in Simao, Yunnan in 2012, with a dry weight of 15 kg, crushed, and extracted three times with 95% ethanol at room temperature by cold soaking (25 liters each time), for 5 days each time. Recover and concentrate under reduced pressure to obtain 1100 g of the extract, which was subjected to silica gel column chromatography and eluted with petroleum ether / acetone mixed solvent gradient (99:1 to 0:100) to obtain 7 components A-G. Component E (180 g) was subjected to silica gel column chromatography and eluted with a gradient of chloroform / methanol mixed solvent (40:1 to 5:1) to obtain three components E1-E3. Component E1 was repeatedly chromatographed on a Sephadex LH-20 column and eluted with methanol to obtain 5.3 g of pure compound borapetoside E. Identification of compound structures was confirmed by comparison and interpretation of spectral data.
[0023] 1. Effect of Borapetoside E on high-fat diet (HFD)-induced hyperglycemia in mice...
Embodiment 2
[0049] Preparation of health food:
[0050] Take 15.5 mg of borapetoside E, add 200 mg of starch, 66.6 mg of lactose, 1 mg of menthol, and 50.6 mg of sodium carboxymethyl starch to make lozenges as a health food.
Embodiment 3
[0052] Preparation of injection preparations:
[0053] According to the method of Example 1, 50 mg of the compound borapetoside E of the present invention was first obtained, which was dissolved in 2 milliliters of propylene glycol, and the resulting solution was filtered and packed into ampoules under aseptic conditions.
PUM
Login to View More Abstract
Description
Claims
Application Information
- IPC
- A61K31/7048; A61P3/06; A61P3/10; A23L33/105; A23L33/125
- CPC
- A23V2002/00; A61K31/7048; A23V2200/328; A23V2250/21; A23V2250/60
- Inventors
- 熊文勇; 刘吉开



